Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.57B | 3.49B | 3.57B | 3.32B | 2.55B | 2.26B | Gross Profit |
859.30M | 848.00M | 857.40M | 763.40M | 583.50M | 550.10M | EBIT |
306.05M | 0.00 | 306.80M | 343.60M | 360.90M | 211.90M | EBITDA |
453.30M | 472.00M | 507.30M | 477.80M | 463.20M | 351.60M | Net Income Common Stockholders |
185.60M | 142.00M | 164.60M | 155.70M | 243.10M | 24.80M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
577.00M | 577.00M | 708.00M | 495.50M | 559.10M | 587.20M | Total Assets |
4.58B | 4.58B | 4.85B | 4.07B | 3.91B | 3.05B | Total Debt |
1.82B | 1.82B | 2.00B | 1.67B | 1.59B | 1.16B | Net Debt |
1.24B | 1.24B | 1.31B | 1.18B | 1.03B | 572.20M | Total Liabilities |
3.20B | 3.20B | 3.49B | 3.03B | 3.09B | 2.39B | Stockholders Equity |
1.20B | 1.20B | 1.20B | 1.00B | 785.90M | 646.10M |
Cash Flow | Free Cash Flow | ||||
311.90M | 288.00M | 320.20M | 77.10M | -343.90M | 162.10M | Operating Cash Flow |
496.40M | 433.00M | 499.70M | 233.80M | -91.80M | 319.00M | Investing Cash Flow |
-333.90M | -154.00M | -482.00M | -199.70M | -128.90M | -137.90M | Financing Cash Flow |
-312.00M | -409.00M | 178.00M | -83.90M | 197.70M | -17.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $65.15B | 19.20 | 16.00% | 1.67% | 1.78% | 15.53% | |
80 Outperform | £10.49B | 36.48 | 15.48% | 0.79% | 11.94% | 20.48% | |
74 Outperform | £33.69B | 20.24 | 29.81% | 1.83% | 0.64% | -5.66% | |
69 Neutral | £1.57B | 13.07 | 11.81% | 4.74% | -4.96% | -13.52% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% | |
60 Neutral | £3.60B | 19.79 | -0.02% | 6.33% | -30.83% | ― |
RHI Magnesita reported its 2024 full-year results, showcasing resilience in margin and cash flow despite challenging market conditions. The company’s revenue slightly declined by 2% to €3,487 million, while adjusted EBITA remained stable at €407 million. Strategic moves included the acquisition of Resco, contributing to a total M&A deal value of €1.2 billion since December 2021, and a record recycling rate of 14.2%. Despite weak market demand, particularly in China, the company maintained strong operational efficiency and cost discipline. Looking ahead, RHI Magnesita anticipates modest growth in adjusted EBITA for 2025, supported by the Resco acquisition and ongoing network optimization efforts.
RHI Magnesita has announced that it will release its full-year financial results for 2024 on February 27, 2025. This announcement underscores the company’s strategic positioning in the market, as it continues to leverage its substantial scale and global presence. The forthcoming results are anticipated to provide insights into the company’s performance and its adaptation to market trends, which could have implications for its operations and stakeholders.
RHI Magnesita announced that its total issued share capital, as of January 31, 2025, consists of 47,197,269 ordinary shares, with 2,280,436 of these held in treasury, resulting in 47,197,269 shares having voting rights. This information is crucial for shareholders and others with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules, as it determines the denominator for calculating changes in their interest in the company.
RHI Magnesita has completed its $410 million acquisition of Resco Group, a US-based producer of alumina monolithics and various refractories, enhancing its market presence in North America. The acquisition is expected to bolster RHI Magnesita’s product portfolio, supply security, and operational efficiency, while generating synergies through supply chain optimization and increased local production in the US and Canada. The transaction reflects the company’s strategic focus on expanding in regions with dynamic economic growth, particularly in the alumina-based refractories sector.
RHI Magnesita announced that as of December 31, 2024, its issued share capital included 47,195,936 ordinary shares, with an additional 2,281,769 shares held in treasury. This update on voting rights is crucial for shareholders to determine their notification obligations under regulatory guidelines, impacting how they manage their interests in the company.